Whistleblowers Assail Gilead's Escobar Defense At High Court
Gilead Sciences Inc. is trying to escape a multibillion-dollar False Claims Act suit by wrongly asserting that the federal government clearly kept buying drugs despite knowledge of manufacturing violations, whistleblowers told...To view the full article, register now.
Already a subscriber? Click here to view full article